Capital Allocation Par Naya Focus
Indoco Remedies ne apna ophthalmic business Sunways (India) Private Limited ko ₹110 crore mein bech diya hai. Ye ek strategic move hai jisme company ne ek chhota sa segment (jo last fiscal year mein Indoco ke standalone revenue ka sirf 3.2% tha) se bahar nikalne ka faisla kiya hai. Is deal se mile paise ko ab Indoco apne core strengths, yaani Active Pharmaceutical Ingredients (APIs) aur complex generic formulations par invest karegi.
Financial Pressure Ko Kam Karne Ki Koshish
Ye deal company par chal rahe financial pressure ko kam karne ke liye ek bada kadam hai. Indoco ne FY26 ke fourth quarter mein interest expenses mein ₹45.92 crore ka sharp increase report kiya tha, jo ab tak ka sabse high hai. Is wajah se interest coverage ratio 1.0x se neeche chala gaya tha. Iska natija ye hua ki FY26 mein company ko ₹98.70 crore ka consolidated net loss hua, bhale hi overall revenue badha ho. Sunways, jisko private equity ka support hai, is acquisition ko apne ophthalmic business ko expand karne ka ek accha mauka maan rahi hai.
Abhi Bhi Kuch Challenges Hain
Halanki ye deal immediate cash laane mein madad karegi, Indoco ki financial structure abhi bhi ek concern bani hui hai. Company ka debt-to-EBITDA ratio 3.78x hai, jo batata hai ki abhi aur financial adjustments ki zaroorat hai. High finance costs ne Indoco ki profitability ko kaafi affect kiya hai, jisse company interest rate changes ke liye vulnerable ho gayi hai. Investors ko yahan thoda caution dikhane ki zaroorat hai, kyunki ye divestment sirf short-term relief de sakti hai aur company ki underlying operational cost issues ko permanently solve nahi kar sakti.
Aage Kya?
Is strategy ki success Indoco ki ability par depend karegi ki wo kitne effective tareeke se is proceeds ko apne USFDA-compliant facilities aur API pipeline mein reinvest kar sakti hai. Market ab dekh rahi hai ki kya ye sale assets ko monetize karne ke ek sustained effort ki shuruat hai ya sirf immediate debt reduction ka ek step hai. Company ki future profitability is baat par nirbhar karegi ki wo revenue growth ko actual profits mein kaise badal pati hai.
